MedTrace Logo

Effects of a 10 Component Dietary Supplement on Health and the Quality of Life

NCT03052491 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 15

Last updated 2017-02-14

No results posted yet for this study

Summary

This open-label field trial evaluates the effects of treatment with a multi-pathway dietary supplement (Stem Cell 100+) that has been commercially available for several years. The objective of the intervention trial is to determine if normal subjects over 35 years of age experience any observable health benefits from the dietary supplement as to their blood pressure, pulse rate, blood cholesterol, lung capacity, stress levels, or self reported changes in markers of overall health and life expectancy.

Conditions

  • Blood Pressure
  • HDL Low
  • Stress
  • Lung Function Decreased
  • Quality of Life
  • Energy Supply; Deficiency
  • Concentration Ability Impaired
  • Joint Instability
  • Immune Deficiency

Interventions

DIETARY_SUPPLEMENT

Stem Cell 100+

Open-Label 10-Component Dietary Supplement

Sponsors & Collaborators

  • Centagen, Inc.

    lead INDUSTRY

Principal Investigators

  • Bryant Villeponteau, Ph.D. · Centagen, Inc.

Study Design

Allocation
NA
Purpose
PREVENTION
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
35 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2016-03-12
Primary Completion
2016-08-24
Completion
2016-08-24

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03052491 on ClinicalTrials.gov